Friday November 27, 2020

State admits it has no timeline for cheaper prices on most widely-used drugs

It is still not known when patients and the health service will benefit from reduced prices on the top 20 most commonly prescribed medicines.

Susan Mitchell

Deputy Editor and Health Editor

@susmitchellsbp
25th May, 2013

It is still not known when patients and the health service will benefit from reduced prices on the top 20 most commonly prescribed medicines. This is despite the passing of the Health (Pricing and Supply of Medical Goods) Bill 2012 through both Houses of the Oireachtas last week.

The government has repeatedly said that the long-awaited legislation, which promotes price competition among medicine suppliers and aims to ensure that lower prices are paid for these medicines, would...

Subscribe from just €1 for the first month!

Exclusive offers:

All Digital Access + eReader

Trial

€1

Unlimited Access for 1 Month

Then €19.99 a month after the offer period.

Get basic
*New subscribers only
You can cancel any time.

Annual

€200

€149 For the 1st Year

Unlimited Access for 1 Year

You can cancel any time.

Quarterly

€55

€42

90 Day Pass

You can cancel any time.

2 Yearly

€315

€248

Unlimited Access for 2 Years

This product does not auto-renew

Team Pass

Get a Business Account for you and your team

Share this post

Related Stories

The best writing and and the biggest stories of 2019 from the Business Post

Richie Oakley | 10 months ago

Denis O’Brien is back in court, residents continue to fight the Council on halting site and a row surfaces in government over rent control proposals

Leanna Byrne | 5 years ago